These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2927660)

  • 41. Magnetic resonance imaging and Hallervorden-Spatz syndrome.
    Trimble M
    CNS Spectr; 2003 Jun; 8(6):420. PubMed ID: 12868452
    [No Abstract]   [Full Text] [Related]  

  • 42. Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).
    Haraguchi T; Terada S; Ishizu H; Yokota O; Yoshida H; Takeda N; Kishimoto Y; Katayama N; Takata H; Akagi M; Kuroda S; Ihara Y; Uchitomi Y
    Neuropathology; 2011 Oct; 31(5):531-9. PubMed ID: 21276079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of Hallervorden-Spatz disease: progressive and intractable dystonia controlled by bilateral thalamotomy.
    Tsukamoto H; Inui K; Taniike M; Nishimoto J; Midorikawa M; Yoshimine T; Kato A; Ikeda T; Hayakawa T; Okada S
    Brain Dev; 1992 Jul; 14(4):269-72. PubMed ID: 1443412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Images in neurology. Neurodegeneration with pantothenate kinase syndrome: retinal and magnetic resonance imaging findings.
    Gadodia A; Kumar A; Sankhyan N; Sharma S; Vasisht N
    Arch Neurol; 2009 Jun; 66(6):798-9. PubMed ID: 19506146
    [No Abstract]   [Full Text] [Related]  

  • 45. Hallervorden Spatz disease.
    Rao C; Murthy V; Hegde R; Asha ; Vishwanath
    Indian J Pediatr; 2003 Jun; 70(6):513-4. PubMed ID: 12921323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity.
    Eidelberg D; Sotrel A; Joachim C; Selkoe D; Forman A; Pendlebury WW; Perl DP
    Brain; 1987 Aug; 110 ( Pt 4)():993-1013. PubMed ID: 2888513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological study of familial late infantile Hallervorden-Spatz disease: a particular form of neuroacanthocytosis.
    Malandrini A; Fabrizi GM; Bartalucci P; Salvadori C; Berti G; Sabò C; Guazzi GC
    Childs Nerv Syst; 1996 Mar; 12(3):155-60. PubMed ID: 8697459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myopathic involvement in two cases of Hallervorden-Spatz disease.
    Malandrini A; Bonuccelli U; Parrotta E; Ceravolo R; Berti G; Guazzi GC
    Brain Dev; 1995; 17(4):286-90. PubMed ID: 7503394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hallervorden-Spatz disease: late infantile type.
    Singhi PD; Mitra S
    J Child Neurol; 1997 Jun; 12(4):281-2. PubMed ID: 9203072
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of axonal involvement in Hallervorden-Spatz disease with magnetic resonance spectroscopy.
    Kitis O; Tekgul H; Erdemir G; Polat M; Serdaroglu G; Tosun A; Coker M; Gokben S
    J Neuroradiol; 2006 Apr; 33(2):129-32. PubMed ID: 16733428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology.
    Defendini R; Markesbery WR; Mastri AR; Duffy PE
    J Neurol Sci; 1973 Sep; 20(1):7-23. PubMed ID: 4355342
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hallervorden-Spatz disease].
    Ohno M; Goto I
    Nihon Rinsho; 1993 Nov; 51(11):2957-61. PubMed ID: 8277577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
    Müller T; Amoiridis G; Kuhn W; Przuntek H
    Eur Neurol; 1999; 42(4):240-1. PubMed ID: 10567823
    [No Abstract]   [Full Text] [Related]  

  • 54. Nonspecific accumulation of metals in the globus pallidus in Hallervorden-Spatz disease.
    Goldberg W; Allen N
    Trans Am Neurol Assoc; 1979; 104():106-8. PubMed ID: 553381
    [No Abstract]   [Full Text] [Related]  

  • 55. Computed tomography in Hallervorden-Spatz disease.
    Dooling EC; Richardson EP; Davis KR
    Neurology; 1980 Oct; 30(10):1128-30. PubMed ID: 7191506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hallervorden-Spatz disease. Late infantile and adult types, report of two cases.
    Rozdilsky B; Cumings JN; Huston AF
    Acta Neuropathol; 1968 Jan; 10(1):1-16. PubMed ID: 5640114
    [No Abstract]   [Full Text] [Related]  

  • 57. Follow-up magnetic resonance imaging in Hallervorden-Spatz disease.
    Brouwer OF; Laboyrie PM; Peters AC; Vielvoye GJ
    Clin Neurol Neurosurg; 1992; 94 Suppl():S57-60. PubMed ID: 1320520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Striatal and pontocerebellar hypoperfusion in Hallervorden-Spatz syndrome.
    Castelnau P; Zilbovicius M; Ribeiro MJ; Hertz-Pannier L; Ogier H; Evrard P
    Pediatr Neurol; 2001 Aug; 25(2):170-4. PubMed ID: 11551749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Late onset familial Hallervorden-Spatz disease: MR findings in two sisters.
    Ambrosetto P; Nonni R; Bacci A; Gobbi G
    AJNR Am J Neuroradiol; 1992; 13(1):394-6. PubMed ID: 1595483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Magnetic resonance diagnosis of Hallervorden-Spatz disease].
    Bonetti M; Prandini F; Gasparotti R; Pavia M; Crispino M; Pittiani F
    Radiol Med; 1994 Dec; 88(6):869-70. PubMed ID: 7878250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.